Publications by authors named "Sushanth Jeyakumar"

Claim this Profile
S
Societal burden of the US opioid epidemic over the next 15 years and the potential impact of effective non-opioid treatments for pain.
Jeromie M Ballreich, Sushanth Jeyakumar, Kenna Garrison, Andrea Lopez, Benjamin G Cohen

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the natural history component of an early economic model for primary sclerosing cholangitis.
Christopher Bowlus, Cynthia Levy, Kris V Kowdley, Nandita Kachru, Sushanth Jeyakumar

Orphanet J Rare Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost-Effectiveness of Tenofovir Alafenamide for Chronic Hepatitis B Virus in Taiwan.
Elise Chia-Hui Tan, Alon Yehoshua, Sushanth Jeyakumar, Pongo Peng, Amy Lin

MDM Policy Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece.
Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, Sushanth Jeyakumar, Nathaniel J Smith

J Comp Eff Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term health and economic benefits of switching to tenofovir alafenamide versus continuing on entecavir in chronic hepatitis B patients with low-level viremia in Saudi Arabia.
Faisal M Sanai, Mohammed Aljawad, Abdullah Saeed Alghamdi, Alon Yehoshua, Abdullah Khathlan, Sushanth Jeyakumar

Saudi J Gastroenterol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources.
Lianne Barnieh, Rachel Beckerman, Sushanth Jeyakumar, Alice Hsiao, James Jarrett

Infect Dis Ther· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Bijal D Shah, Nathaniel J Smith, Chaoling Feng, Sushanth Jeyakumar, Jean-Gabriel Castaigne

Adv Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population.
Jordan J Karlitz, A Mark Fendrick, Jay Bhatt, Gloria D Coronado, Sushanth Jeyakumar

Popul Health Manag· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis.
Rachel Beckerman, Andrea Gori, Sushanth Jeyakumar, Jakob J Malin, Roger Paredes

Sci Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
Deborah A Fisher, Jordan J Karlitz, Sushanth Jeyakumar, Nathaniel Smith, Paul Limburg

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis